title: Prolonged amelioration of acute lung allograft rejection by sequential overexpression of human interleukin-10 and hepatocyte growth factor in rats.
abstract: The effect of prolonged electroporation-mediated human interleukin-10 (hIL-10) overexpression 24 hours before transplantation, combined with sequential human hepatocyte growth factor (HGF) overexpression into skeletal muscle on day 5, on rat lung allograft rejection was evaluated. Left lung allotransplantation was performed from Brown-Norway to Fischer-F344 rats. Gene transfer into skeletal muscle was enhanced by electroporation. Three groups were studied: group I animals (n = 5) received 2.5 μg pCIK-hIL-10 (hIL-10/CMV [cytomegalovirus] early promoter enhancer) on day -1 and 80 μg pCIK-HGF (HGF/CMV early promoter enhancer) on day 5. Group II animals (n = 4) received 2.5 μg pCIK-hIL-10 and pUbC-hIL-10 (hIL-10/pUbC promoter) on day -1. Control group III animals (n = 4) were treated by sham electroporation on days -1 and 5. All animals received daily nontherapeutic intraperitoneal dose of cyclosporin A (2.5 mg/kg) and were sacrificed on day 15. Graft oxygenation and allograft rejection were evaluated. Significant differences were found between study groups in graft oxygenation (Pao(2)) (P = .0028; group I vs. groups II and III, P < .01 each). Pao(2) was low in group II (31 ± 1 mm Hg) and in group III controls (34 ± 10 mm Hg), without statistically significant difference between these 2 groups (P = .54). In contrast, in group I, Pao(2) of recipients sequentially transduced with IL-10 and HGF plasmids was much improved, with 112 ± 39 mm Hg (vs. groups II and III; P < .01 each), paralleled by reduced vascular and bronchial rejection (group I vs. groups II and III, P < .021 each). Sequential overexpression of anti-inflammatory cytokine IL-10, followed by sequential and overlapping HGF overexpression on day 5, preserves lung function and reduces acute lung allograft rejection up to day 15 post transplant as compared to prolonged IL-10 overexpression alone.
authors: Division of General Thoracic Surgery, University Hospital Bern, University of Bern, Switzerland.
authors: Richard
authors: R
authors: Fakin
authors: Jürg
authors: J
authors: Hamacher
authors: Mathias
authors: M
authors: Gugger
authors: Amiq
authors: A
authors: Gazdhar
authors: Helen
authors: H
authors: Moser
authors: Ralph Alexander
authors: RA
authors: Schmid
mesh_terms: D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006084:Graft Rejection / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage* / Q000097:blood / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D016753:Interleukin-10 / Q000008:administration & dosage* / Q000097:blood / Q000235:genetics; D008168:Lung / Q000473:pathology; D016040:Lung Transplantation; D008297:Male; D011659:Pulmonary Gas Exchange; D051381:Rats; D011914:Rats, Inbred BN; D011916:Rats, Inbred F344; D014184:Transplantation, Homologous / Q000009:adverse effects
chemical_list: C508609:IL10 protein, human; D016753:Interleukin-10; D017228:Hepatocyte Growth Factor